These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1782010)

  • 1. Evidence for kinetic and immunologic heterogeneity of dihydrofolate reductase in L1210 leukemia cells.
    Iqbal MP; Rothenberg SP; da Costa M
    Biochem Med Metab Biol; 1991 Oct; 46(2):196-207. PubMed ID: 1782010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic heterogeneity of dihydrofolate reductase from methotrexate sensitive and resistant L1210 leukemia cells.
    Iqbal MP; Rothenberg SP; Larosa C
    Proc Soc Exp Biol Med; 1985 Oct; 180(1):98-102. PubMed ID: 2412235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanism of resistance to methotrexate. NADPH but not NADH stimulation of methotrexate binding to dihydrofolate reductase.
    Kamen BA; Whyte-Bauer W; Bertino JR
    Biochem Pharmacol; 1983 Jun; 32(12):1837-41. PubMed ID: 6882460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a high-molecular-weight nonfunctional protein in L1210 leukemia cells with common antigenic determinants to dihydrofolate reductase.
    Rothenberg SP; Iqbal MP
    Cancer Res; 1983 Feb; 43(2):529-35. PubMed ID: 6184148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interaction between methotrexate and dihydrofolate reductase on DNA synthesis in L1210 cells in vitro.
    Bender RA; Makula DM
    Br J Cancer; 1978 Mar; 37(3):403-10. PubMed ID: 638018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nonfunctional protein in human leukemia cells reacts with antiserum to dihydrofolate reductase from L1210 leukemia cells.
    Iqbal MP; Rothenberg SP
    Life Sci; 1981 Aug; 29(7):689-96. PubMed ID: 6168882
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple forms of L1210 dihydrofolate reductase differing in affinity for methotrexate.
    Duffy TH; Beckman SB; Huennekens FM
    Biochem Biophys Res Commun; 1984 Feb; 119(1):352-8. PubMed ID: 6704125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline.
    Wroblewski DH; Bhushan A; Xuan Y; Brinton BT; Tritton TR; Hacker MP
    Cancer Chemother Pharmacol; 1996; 37(4):337-42. PubMed ID: 8548879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation.
    Dicker AP; Waltham MC; Volkenandt M; Schweitzer BI; Otter GM; Schmid FA; Sirotnak FM; Bertino JR
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11797-801. PubMed ID: 8265628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L1210 dihydrofolate reductase: activation and enhancement of methotrexate sensitivity.
    Duffy TH; Sato JK; Vitols KS; Huennekens FM
    Adv Enzyme Regul; 1985; 24():13-25. PubMed ID: 3835818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy.
    Domin BA; Grill SP; Cheng Y
    Cancer Res; 1983 May; 43(5):2155-8. PubMed ID: 6831441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of dihydrofolate reductase from a methotrexate-resistant subline of L1210 cells.
    Duffy TH; Beckman SB; Sato JK; Nagae H; Vitols KS; Huennekens FM
    Adv Enzyme Regul; 1985; 23():3-12. PubMed ID: 4072799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB; Wick MM
    Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate analogues. 23. Synthesis, dihydrofolate reductase affinity, cytotoxicity, and in vivo antitumor activity of some putative degradation products of methotrexate-poly(L-lysine) conjugates.
    Rosowsky A; Forsch RA; Freisheim JH; Galivan J; Wick M
    J Med Chem; 1984 Jul; 27(7):888-93. PubMed ID: 6737432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
    Goldman ID; Matherly LH
    NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of amino-acid sequence in dihydrofolate reductase from a human methotrexate-resistant cell line KB/6b. Structural and kinetic comparison with mouse L1210 enzyme.
    Pan YC; Domin BA; Li SS; Cheng YC
    Eur J Biochem; 1983 May; 132(2):351-9. PubMed ID: 6840092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced forms of aminopterin and methotrexate in L1210 lymphoma.
    Makulu DR; Fölsch E
    J Natl Cancer Inst; 1977 Jul; 59(1):245-9. PubMed ID: 875056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
    Whitehead VM
    Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialkyl esters of methotrexate and 3',5'-dichloromethotrexate: synthesis and interaction with aldehyde oxidase and dihydrofolate reductase.
    Johns DG; Farquhar D; Wolpert MK; Chabner BA; Loo TL
    Drug Metab Dispos; 1973; 1(3):580-9. PubMed ID: 4149453
    [No Abstract]   [Full Text] [Related]  

  • 20. A fluorescent analogue of methotrexate as a probe for folate antagonist molecular receptors.
    Susten SS; Kempton RJ; Black AM; Freisheim JH
    Biochem Pharmacol; 1984 Jun; 33(12):1957-62. PubMed ID: 6732854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.